Diagnostics News and Research

RSS

Penn State researchers create smart, targeted system to attack specific cancers types

Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells.

4 Jan 2017

EKF Diagnostics launch new website for customers in USA/Canada

EKF Diagnostics PLC announces the launch of its new USA domestic website, replacing stanbio.

From EKF Diagnostics 3 Jan 2017

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.

30 Dec 2016

Mutations linked to endometrial cancer can be found in uterine lavage fluid before cancer diagnosis

Mutations that have been linked to endometrial cancer can be found in the uterine lavage fluid of pre- and post-menopausal women both with and without detectable cancer, according to a study published in PLOS Medicine by John Martignetti, MD, PhD of the Icahn School of Medicine at Mount Sinai and colleagues.

30 Dec 2016

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.

30 Dec 2016

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria -- the energy-producing factory of the cell -- and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.

22 Dec 2016

OIST researchers create novel sensor that detects biomolecules

OIST researchers create a novel sensor capable of measuring both charge and mass of biomolecules with potential applications in healthcare diagnostics.

22 Dec 2016

Agendia data reveals impact of MammaPrint on adjuvant treatment decisions in breast cancer patients

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, has presented new prospective data demonstrating the strong impact of its 70-Gene Breast Cancer Recurrence assay, MammaPrint, and the corresponding 80-Gene Molecular Subtyping Assay BluePrint, in clinical decision-making for patients with early-stage breast cancer in Germany.

22 Dec 2016

Clinical Genomics introduces new blood-based test for CRC recurrence monitoring

Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera, a blood-based test for colorectal cancer (CRC) recurrence monitoring. Colvera is the result of a decade of research, development and clinical validation in more than 4,000 patients.

22 Dec 2016

FDA expands approved use of G5 Mobile Continuous Glucose Monitoring System

The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.

21 Dec 2016

Wellcome Trust Sanger Institute establishes spin-out company, Microbiotica

Cambridge Innovation Capital plc, a Cambridge-based investor in technology and healthcare companies, and IP Group plc, the developer of intellectual property-based businesses, announce the creation of Microbiotica Ltd, a newly formed spin-out company from the UK’s Wellcome Trust Sanger Institute based at the Wellcome Genome Campus in Hinxton, Cambridge.

21 Dec 2016

Hormone receptor could be potential biomarker for gastric cancer, research shows

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, the Veterans Affairs Medical Center in Miami, and Shantou University Medical College in China, have shown that the hormone receptor GHRH-R could be a potential biomarker for gastric cancer, enabling earlier diagnoses and better staging.

21 Dec 2016

How can we tackle antimicrobial resistance?

Antimicrobial resistance happens when bugs, like bacteria, fungi or viruses, change, or evolve, when they’re exposed to drugs, like antibiotics, antifungals, or antivirals. Bugs that develop antimicrobial resistance are sometimes referred to as ‘superbugs’.

20 Dec 2016

AMP publishes joint guidelines for interpretation, reporting of sequence variants in cancer

The Association for Molecular Pathology (AMP), the premier global, non-profit molecular diagnostics professional society, today published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing (NGS)-based cancer tests and establish standardized classification, annotation, interpretation, and reporting conventions for somatic sequence variants.

17 Dec 2016

Sphere Medical launches next generation Proxima for bedside blood gas and glucose analysis

Sphere Medical, an innovative company in critical care monitoring and diagnostics equipment, has launched its next generation CE-marked Proxima system.

17 Dec 2016

Portable detection system can rapidly identify virulent, multi-drug resistant pathogens in remote areas

A team of researchers has developed a portable detection system that can rapidly identify some of the most virulent, often multi-drug resistant pathogens.

16 Dec 2016

Excelitas launches new X-Cite Vitae vIR system for endoscopy and surgical visualization applications

Excelitas Technologies Corp., a global technology leader focused on delivering innovative, customized photonic solutions, adds X-Cite VitaeTM vIR to its popular X-Cite fluorescence illuminator product line. X-Cite Vitae vIR is a customizable, multi-wavelength illumination system designed for high precision medical illumination and diagnostic applications.

From Excelitas Technologies 16 Dec 2016

Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.

Pacific Edge Limited, a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the commercial launch of the third product in the Company's Cxbladder family of products, Cxbladder Monitor, in the United States.

15 Dec 2016

Diagnostics News and Research

Penn State researchers create smart, targeted system to attack specific cancers types

EKF Diagnostics launch new website for customers in USA/Canada

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Mutations linked to endometrial cancer can be found in uterine lavage fluid before cancer diagnosis

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

New study shows efficacy of Ebola vaccine in offering protection against disease

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

OIST researchers create novel sensor that detects biomolecules

Agendia data reveals impact of MammaPrint on adjuvant treatment decisions in breast cancer patients

Clinical Genomics introduces new blood-based test for CRC recurrence monitoring

FDA expands approved use of G5 Mobile Continuous Glucose Monitoring System

Wellcome Trust Sanger Institute establishes spin-out company, Microbiotica

Hormone receptor could be potential biomarker for gastric cancer, research shows

How can we tackle antimicrobial resistance?

AMP publishes joint guidelines for interpretation, reporting of sequence variants in cancer

Sphere Medical launches next generation Proxima for bedside blood gas and glucose analysis

Portable detection system can rapidly identify virulent, multi-drug resistant pathogens in remote areas

Excelitas launches new X-Cite Vitae vIR system for endoscopy and surgical visualization applications

Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News